The Alabama Department of Public Health is working with other health agencies to investigate an injectable anti-inflammatory drug prepared by a compounding manufacturer in Tennessee.
Main Street Family Pharmacy of Newbern, Tenn. shipped the tainted medicine to clinics in 13 states.
The investigation began after the U.S. Food and Drug Administration was notified of seven people who developed infections or adverse reactions after receiving injections of methylprednisolone acetate (MPA). It’s the same drug that was linked to last year’s deadly outbreak of fungal meningitis.
The investigation is in an early stage and is rapidly evolving, according to Dr. Mary McIntyre of the ADPH.
Was this article valuable?
Here are more articles you may enjoy.
California’s Surplus Lines HO Market’s New Phase Driven by Access, Not Wildfire Risk 
Toilet Paper Warehouse in California Destroyed by Fire; Employee Arrested 
Hail A Growing Loss Driver on Rising Tide of Severe Convective Storm Risk, Allianz Says 
US Truck Rates at Highest Since 2022 Add to Inflation Pressures 
Want to stay up to date?
Get the latest insurance news
sent straight to your inbox.